PlainMeds provides educational information only. This is not medical advice. Always consult your doctor or pharmacist.

alirocumab vs pravastatin

Side-by-side comparison of alirocumab and pravastatin Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.

Drug Class
alirocumab PCSK9 Inhibitor
pravastatin HMG-CoA Reductase Inhibitor (Statin)
Type
alirocumab Prescription
pravastatin Prescription
Summary
alirocumab

Praluent is a medicine that can lower cholesterol. It can also lower the risk of heart problems like heart attack or stroke in some adults.

pravastatin

Pravastatin is a drug that lowers cholesterol. It belongs to a class of drugs called statins.

What It Treats
alirocumab

Praluent is used to lower LDL cholesterol (bad cholesterol). It is used along with diet and exercise in adults with high cholesterol. It is also used in adults and children 8 years and older who have a genetic condition that causes high cholesterol.

pravastatin

Pravastatin helps lower bad cholesterol and fats (like triglycerides) in your blood, while raising good cholesterol. It can help prevent heart attacks, strokes, and the need for procedures to open blocked arteries. It is used along with a healthy diet to treat high cholesterol and other fat disorders in adults and children 8 years and older.

How It Works
alirocumab

Praluent is a PCSK9 inhibitor. It works by blocking a protein in your body called PCSK9. Blocking this protein helps your body remove LDL cholesterol from your blood.

pravastatin

Pravastatin works by blocking a substance your body needs to make cholesterol. This helps to lower the amount of cholesterol in your blood. Lowering cholesterol helps to prevent heart disease and stroke.

Common Side Effects
alirocumab
  • Injection site reactions (redness, itching, swelling, pain)
  • Flu
  • Muscle pain
  • Diarrhea
pravastatin
  • Muscle pain
  • Nausea
  • Vomiting
  • Diarrhea
  • Headache
FAERS Reports
alirocumab
  • Muscle pain 1,655
  • Missed dose 1,364
  • Pain at injection site 1,278
  • Muscle spasms 1,162
  • Joint pain 1,053
pravastatin
  • Tiredness 1,261
  • Diarrhea 1,095
  • Feeling sick to your stomach 954
  • Shortness of breath 928
  • Headache 842
Serious Warnings
alirocumab

Serious allergic reactions have happened with Praluent, sometimes requiring hospitalization. If you have signs of a serious allergic reaction, stop using Praluent and get medical help right away.

pravastatin

Pravastatin can sometimes cause muscle problems, including muscle pain, tenderness, or weakness. In rare cases, this can lead to serious muscle damage called rhabdomyolysis, which can cause kidney failure. Tell your doctor right away if you have unexplained muscle pain, tenderness, or weakness, especially if you also have a fever or feel sick. This medicine can also cause liver problems. Your doctor should do blood tests to check your liver before you start taking pravastatin and if you have any symptoms of liver problems.

Pregnancy
alirocumab

There is not enough information about Praluent use during pregnancy to know if it is safe. If you are pregnant or plan to become pregnant, talk to your doctor before using Praluent.

pravastatin

You should not take pravastatin if you are pregnant. It can harm your unborn baby. If you become pregnant while taking pravastatin, stop taking it right away and tell your doctor.

Also Compare — Nearby Drugs

How to Read This alirocumab vs pravastatin Comparison

alirocumab is classified in the PCSK9 Inhibitor drug class, while pravastatin sits within the HMG-CoA Reductase Inhibitor (Statin) class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are prescription-only, so a licensed provider must authorize use.

Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, alirocumab has 6,512 submissions while pravastatin has 5,080. Those figures reflect cumulative reporting volume — not per-patient risk — so older, widely dispensed drugs typically look worse on count alone. No direct interaction between these two drugs is listed in our FDA-derived dataset, though co-prescription still warrants pharmacist review. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.

A table cannot substitute for clinical judgment. Effectiveness, tolerability, drug-drug interactions with your other medications, kidney and liver function, pregnancy status, insurance formulary, and price all feed into a decision that only a licensed prescriber can make responsibly. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This page is for educational purposes only, is not medical advice, and should not be used to self-switch between alirocumab and pravastatin — always consult your physician or pharmacist first.

Important: This comparison is for informational purposes only. Drug effects vary between individuals. Always consult your doctor or pharmacist for personalized medical advice.